Loading viewer...
investor_presentation
Format: PDF investor_presentation
Chiasma's May 2018 business update highlights clinical achievements and regulatory progress, focusing on the CHIASMA OPTIMAL trial and future outlook.
investor_presentation
45 Pages
Merck KGaA